{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:56:48Z","timestamp":1792821408993,"version":"4.5.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","euoncology.europeanurology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Urology Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.euo.2026.03.016","type":"journal-article","created":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T09:11:35Z","timestamp":1774861895000},"page":"1005-1007","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Agentic AI for Prostate Cancer: A Vision for Multimodal Clinical Intelligence"],"prefix":"10.1016","volume":"9","author":[{"given":"N.","family":"Papanikolaou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Padhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5242-7060","authenticated-orcid":false,"given":"F.","family":"Sanguedolce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.euo.2026.03.016_b0005","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S1470-2045(24)00220-1","article-title":"Artificial intelligence and radiologists in prostate cancer detection on MRI (PI-CAI): an international, paired, non-inferiority, confirmatory study","volume":"25","author":"Saha","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.euo.2026.03.016_b0010","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/bju.16464","article-title":"External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens","volume":"135","author":"Schmidt","year":"2025","journal-title":"BJU Int"},{"key":"10.1016\/j.euo.2026.03.016_b0015","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s43856-022-00126-3","article-title":"Predicting biochemical recurrence of prostate cancer with artificial intelligence","volume":"2","author":"Pinckaers","year":"2022","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/j.euo.2026.03.016_b0020","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/rpd\/ncae154","article-title":"Utilization of machine learning methods for prediction of acute and late rectal toxicity due to curative prostate radiotherapy","volume":"200","author":"Ozkan","year":"2024","journal-title":"Radiat Prot Dosim"},{"key":"10.1016\/j.euo.2026.03.016_b0025","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3390\/jimaging11100335","article-title":"Artificial intelligence in prostate MRI: current evidence and clinical translation challenges-A narrative review","volume":"11","author":"Bolocan","year":"2025","journal-title":"J Imaging"},{"key":"10.1016\/j.euo.2026.03.016_b0030","doi-asserted-by":"crossref","first-page":"5695","DOI":"10.1007\/s00330-025-11498-0","article-title":"AI and human interactions in prostate cancer diagnosis using MRI","volume":"35","author":"Padhani","year":"2025","journal-title":"Eur Radiol"},{"key":"10.1016\/j.euo.2026.03.016_b0035","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/s12911-021-01732-2","article-title":"A personalized decision aid for prostate cancer shared decision making","volume":"21","author":"Bagshaw","year":"2021","journal-title":"BMC Med Inform Decis Mak"},{"key":"10.1016\/j.euo.2026.03.016_b0040","first-page":"1713","article-title":"Improving the quality of decision-making processes for prostate cancer screening: progress and challenges","volume":"173","author":"Reuland","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.euo.2026.03.016_b0045","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s41746-022-00689-4","article-title":"Integrated multimodal artificial intelligence framework for healthcare applications","volume":"5","author":"Soenksen","year":"2022","journal-title":"NPJ Digit Med"},{"key":"10.1016\/j.euo.2026.03.016_b0050","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1080\/21681805.2019.1675757","article-title":"Performance and inter-observer variability of prostate MRI (PI-RADS version 2) outside high-volume centres","volume":"53","author":"Kohestani","year":"2019","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euo.2026.03.016_b0055","doi-asserted-by":"crossref","first-page":"396.e1","DOI":"10.1016\/j.urolonc.2024.10.002","article-title":"Inter-reader reliability and diagnostic accuracy of PI-RADS scoring between academic and community care networks: how wide is the gap?","volume":"43","author":"Smani","year":"2025","journal-title":"Urol Oncol"},{"key":"10.1016\/j.euo.2026.03.016_b0060","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/21681805.2016.1206619","article-title":"Interobserver variability in Gleason histological grading of prostate cancer","volume":"50","author":"Ozkan","year":"2016","journal-title":"Scand J Urol"},{"key":"10.1016\/j.euo.2026.03.016_b0065","article-title":"The correlation between the Gleason score of the biopsy and that of the prostatectomy patch","volume":"63","author":"Bai","year":"2021","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/j.euo.2026.03.016_b0070","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.8576","article-title":"Overtreatment of prostate cancer in men with limited life expectancy-A global phenomenon?","volume":"8","author":"Daskivich","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.euo.2026.03.016_b0075","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.euo.2024.11.004","article-title":"Reducing overtreatment of prostate cancer patients: revisiting the European Association of Urology pretreatment risk group classification using long-term follow-up data from the European randomized study of screening for prostate cancer Rotterdam","volume":"8","author":"de Vos","year":"2025","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.euo.2026.03.016_b0080","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.29760","article-title":"Trends in active surveillance for men with intermediate-risk prostate cancer","volume":"7","author":"Diven","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["European Urology Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000751?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2588931126000751?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T16:46:57Z","timestamp":1789577217000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2588931126000751"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2588931126000751"],"URL":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.016","relation":{},"ISSN":["2588-9311"],"issn-type":[{"value":"2588-9311","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Agentic AI for Prostate Cancer: A Vision for Multimodal Clinical Intelligence","name":"articletitle","label":"Article Title"},{"value":"European Urology Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.euo.2026.03.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 European Association of Urology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}